Jaguar Health, Inc. (100) | Uncategorized (15)

Recent Contracts

Royalty Interest, dated March 8, 2021, by and between Jaguar Health, Inc. and Streeterville Capital, LLC (Filed With SEC on March 11, 2021)
Royalty Interest, dated December 22, 2020, by and between Jaguar Health, Inc. and Irving Park Capital, LLC (Filed With SEC on December 29, 2020)
Royalty Interest, dated October 8, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on October 9, 2020)
At The Market Offering Agreement, dated October 5, 2020, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on October 5, 2020)
Global Amendment, dated September 1, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P (Filed With SEC on September 2, 2020)
Jaguar Health, Inc. New Employee Inducement Award Plan (Filed With SEC on June 19, 2020)
Form of Inducement Letter for Bridge Warrants (Filed With SEC on May 22, 2020)
Form of Inducement Letter for Original Warrants (Filed With SEC on May 22, 2020)
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1945, as amended (Filed With SEC on April 3, 2020)
Leak-Out Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and the Holder named therein (Filed With SEC on March 26, 2020)
Royalty Interest, dated March 4, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on March 6, 2020)
Lock-Up Agreement, dated December 23, 2019, by and between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on December 26, 2019)
Promotion Letter, dated September 6, 2019 (Filed With SEC on September 9, 2019)
Form of Leak-out Agreement (Filed With SEC on July 18, 2019)
Form of Amendment Agreement (Filed With SEC on July 5, 2019)